Cleveland BioLabs gets funding for radiation treatment research

09/23/2009 | American City Business Journals

NIH's National Institute of Allergy and Infectious Diseases has given Cleveland BioLabs a $458,512 grant to continue research on Protectan CBLB502, an agent designed to protect against the damages caused by radiation exposure. Currently, no drug is approved for complications from radiation exposure.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA